ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

D X Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7226-7773; OpenAlex author ID A5084316438. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation. Co-author DOI 10.1016/j.bcp.2026.118222 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qingfang Miao · 1 shared paper, 2026 · strength 0.29
- Paper hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and… DOI 10.1016/j.bcp.2026.118222 ↗
Ying Wang · 1 shared paper, 2026 · strength 0.29
- Paper hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and… DOI 10.1016/j.bcp.2026.118222 ↗
Yong‐Su Zhen · 1 shared paper, 2026 · strength 0.29
- Paper hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and… DOI 10.1016/j.bcp.2026.118222 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.